Table 1.
Demographic and clinical features of HIV-1 infected patients
| |
NAIVE¶ |
ART* |
AIDS# |
TOTAL |
|---|---|---|---|---|
| (n = 42) | (n = 54) | (n = 13) | (n = 109) | |
| Gender |
|
|
|
|
| Female |
8 |
14 |
3 |
25 |
| Male |
34 |
40 |
10 |
84 |
| Age (years) |
|
|
|
|
| Median |
46 |
52 |
51 |
50 |
| Range |
22-53 |
38-66 |
47-75 |
22-75 |
| Plasma HIV-1 RNA (copies/ml) |
|
|
|
|
| Median |
16816 |
<50 |
46630 |
1620 |
| Range |
74-309691 |
0-412137 |
22025-402137 |
0-402137 |
| CD4pos T cell count (cells/mm3) |
|
|
|
|
| Median |
380 |
491 |
111.5 |
386.5 |
| Range | 99-1042 | 98-1328 | 3-197 | 3-1328 |
¶Naïve patients for antiretroviral therapy (ART) without a clinical history of opportunistic infections or malignancies associated to HIV-1 infection.
*ART included at least one protease inhibitor, one non-nucleoside reverse-transcriptase inhibitor and /or two nucleoside reverse-transcriptase inhibitors.
#Chronically HIV-1 infected patients either naïve for ART or therapeutic regimen had been discontinued at least 24 months earlier. Clinical history included opportunistic infections or malignancies associated to HIV-1 infection.